Literature DB >> 12833031

Evaluating the role of immunoablative high-dose cyclophosphamide therapy in pemphigus vulgaris.

Carlos H Nousari1, Robert Brodsky, Grant J Anhalt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12833031     DOI： 10.1067/mjd.2003.581

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  5 in total

Review 1.  Seeking approval: present and future therapies for pemphigus vulgaris.

Authors:  Xuming Mao; Aimee S Payne
Journal:  Curr Opin Investig Drugs       Date:  2008-05

2.  High-dose cyclophosphamide without stem cell rescue for the treatment of refractory Behcet's disease.

Authors:  Charles F Henderson; Robert A Brodsky; Richard J Jones; Stuart M Levine
Journal:  Semin Arthritis Rheum       Date:  2011-02-03       Impact factor: 5.532

Review 3.  Current approach to fertility preservation by embryo cryopreservation.

Authors:  Giuliano Bedoschi; Kutluk Oktay
Journal:  Fertil Steril       Date:  2013-03-25       Impact factor: 7.329

Review 4.  Novel therapies for pemphigus vulgaris: an overview.

Authors:  Oliver A Perez; Timothy Patton
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

5.  Therapy of autoimmune bullous diseases.

Authors:  Diya F Mutasim
Journal:  Ther Clin Risk Manag       Date:  2007-03       Impact factor: 2.423
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.